Its now spreading into cardiology, hepatology, nephrology and sleep medicine The Old Narrative: A Weight-Loss Race For a long time, this was a two-horse race: Semaglutide ~1315% weight loss Tirzepatide ~20%+ weight loss Even head-to-head: 20.2% vs 13.7% mean weight loss Nearly 2x more patients hitting 25% weight loss That made the conclusion easy: Tirzepatide wins But that conclusion is already outdated
Glutathione Forms Compared Oral Safety: Excellent Evidence: Strong Side Effects: Minimal (mild GI) Topical Safety: Good Evidence: Moderate Side Effects: Localized only IV (Intravenous) Safety: Poor Evidence: Weak/Flawed Side Effects: Serious risks Myth vs
It is administered through a subcutaneous injection, typically once a week
These are not "ordinary" drugs and should only be prescribed by endocrinologists, cardiologists, or specialist physicians, not even "ordinary doctors" should administer them, Joshi said
timonensis SP2-71.3 in this study (data not shown)